Tech Company Financing Transactions
Pfenex Funding Round
Pfenex, based in San Diego, received $24 million from Dow Venture Capital and Signet Healthcare Partners.
Transaction Overview
Company Name
Announced On
12/10/2009
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Undisclosed
Investors
Dow Venture Capital (Dennis Merens)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10790 Roselle St.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Headquartered in San Diego, California, Pfenex Inc. (NYSE MKT: PFNX) is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jason Grenfell-Gardner
Chief Executive Officer
Eef Schimmelpennink
Chief Financial Officer
Susan Knudson
Chief Medical Officer
Hubert Chen
Vice President
Mayda Mercado
VP - Bus. Development
Patrick Lucy
Browse more venture capital transactions:
Prev: 12/10/2009: Aperto Networks venture capital transaction
Next: 12/10/2009: ClearPoint venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs